Brean

3-D printing stocks are trading lower again in sympathy after ExOne (NASDAQ: XONE) reported downbeat fourth quarter results and issued a weak 2014 revenue outlook on Wednesday afternoon. Brean Capital sees the sector weakness as a sector buying opportunity and RBC had some bullish comments on the...

Shares of Guess? (NYSE: GES) are up 1.8 percent to $29 in the face of a bearish note from Brean Capital. Eric Beder, analyst at Brean, lowered his fourth quarter 2014 earnings per share estimates to $0.69 from $0.80, well below management's EPS guidance of $0.74-$0.84 and the Street consensus...

Brean, Murray, Carret & Co. analyst Ananda Baruah reiterated a Buy rating for shares of Xyratex Ltd. (NASDAQ: XRTX), with a price target of $24 per share. Baruah recommended buying aggressively during unwarranted sell-offs of Xyratex Ltd. stock. The analyst noted that shares of Xyratex Ltd....

Brean, Murray, Carret & Co. analyst Ingrid Yin maintained her Buy rating for shares of China Biologic Products, Inc. (Nasdaq: CBPO) and raised the price target to $20 per share, from the previous price target of $19. The analysts said that China Biologic Products, Inc. had announced that the...